Sorafenib
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33680929-c1c0-4a67-aa2e-1f98b8efd580 | Product name | 1 | 20240501 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-262-01 | Sorafenib | 100 g in 1 JAR | POWDER | 100 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73309-262 | 73309-262-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SORAFENIB | 9ZOQ3TZI87 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sorafenib | SORAFENIB | Golden State Medical Supply, Inc. | faa9d847-2cd5-6538-e053-6394a90aa92b | 2026-07-28 | Warnings, Adverse reactions | sorafenib SORAFENIB |
| sorafenib | SORAFENIB | Upsher-Smith Laboratories, LLC | 68aa4b7f-3f13-4e73-b572-aa6c11a8429c | 2026-07-03 | Warnings, Adverse reactions | sorafenib SORAFENIB |
| sorafenib | SORAFENIB | Yabao Pharmaceutical Co., Ltd. Beijing | 06f442d6-071e-4081-b7f7-40f3b803ab3f | 2026-06-01 | Warnings, Adverse reactions | sorafenib SORAFENIB |
| Sorafenib Tosylate | SORAFENIB | Mylan Pharmaceuticals Inc. | b7919013-1511-44f0-a759-3fa78a9fa178 | 2026-03-18 | Warnings, Adverse reactions | SORAFENIB |
| Sorafenib | SORAFENIB | Torrent Pharmaceuticals Limited | b5305e23-7bc6-44d8-b177-930c47d1653a | 2026-02-11 | Warnings, Adverse reactions | Sorafenib SORAFENIB |
| sorafenib | SORAFENIB | Dr.Reddys Laboratories Inc | 93f9c3b2-d4c5-80d3-5421-8b4c29fbf8a6 | 2024-12-02 | Warnings, Adverse reactions | sorafenib SORAFENIB |
| Nexavar | SORAFENIB | Bayer HealthCare Pharmaceuticals Inc. | b50667e4-5ebc-4968-a646-d605058dbef0 | 2023-08-28 | Warnings, Adverse reactions | SORAFENIB |
| Sorafenib | SORAFENIB | Teva Pharmaceuticals, Inc. | dae598f7-823f-405c-ae31-f924594187b9 | 2022-07-01 | Warnings, Adverse reactions | Sorafenib SORAFENIB |
Adverse event summaries are temporarily unavailable. Other product information remains available.